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Edited by Ned ManteiAbstract Osteoblasts and adipocytes are believed to share a
common progenitor. Peroxisome proliferator-activated receptor
c (PPARc) plays a key role in the switching of these two cell lin-
eages. Here, we demonstrated the diﬀerentiation of ES cells into
an osteoblastic lineage using siRNA against PPARc without the
addition of any osteogenic factors. We found that PPARc-
siRNA downregulated the expression of aP2 mRNA and lipid
accumulation, whereas it upregulated the expression of osteocal-
cin and calcium deposition. These results suggested that ES cells
were directed into an osteoblastic lineage. Therefore, transient
suppression using PPARc-siRNA may be a novel tool to induce
diﬀerentiation of ES cells into osteoblasts.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Production of various functional cells from ES cells is a crit-
ical issue for regenerative medicine. The diﬀerentiation of ES
cells into osteoblasts has been achieved using a combination
of retinoic acid (RA), ascorbic acid, b-glycerophosphate, dexa-
methasone (Dex), and bone morphogenetic protein-2 (BMP-2)
[1–4,24].
Interestingly, it has been reported that osteoblasts and adi-
pocytes share common progenitors in the bone marrow and
their relationship with regard to diﬀerentiation is reciprocal
[5,6]. In addition, clinical evidence that a decrease in bone vol-
ume of age-related osteoporosis is accompanied by an increase
in marrow adipose tissue also implies the possible reciprocal
relationship of these lineages [7,8].
PPARc is a transcription factor abundantly expressed in
adipose tissue and plays a key role in adipocyte diﬀerentiation,
insulin sensitivity and immune responses [9]. The biological
role of PPARc had been investigated by using PPARc-deﬁ-
cient mice generated by gene targeting [9]. The heterozygous
PPARc-deﬁcient (PPARc+/) mice exhibited resistance to
high-fat diet-induced obesity and insulin resistance [9,10]. This*Corresponding author. Fax: +81 77 548 2414.
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doi:10.1016/j.febslet.2006.06.057PPARc insuﬃciency enhanced osteogenesis from bone marrow
progenitors in vivo and ex vivo [11].
Furthermore, homozygous PPARc-deﬁcient (PPARc/)
ES cells were unable to diﬀerentiate into adipocytes and spon-
taneously diﬀerentiated into osteoblasts [11]. This evidence
suggested that PPARc plays a key role in switching the com-
mitment of the common progenitor into either adipocytic or
osteoblastic lineages in bone marrow. Therefore, we consid-
ered that osteoblasts might also be induced from diﬀerentiated
ES cells by suppressing PPARc.
Recently, RNA interference (RNAi) has become a powerful
tool for selectively silencing the expression of the target gene
[12]. We have established an eﬃcient method to suppress spe-
ciﬁc genes using chemically synthesized siRNA in ES cells [13].
Modulating the cell fate by suppressing the expression of a key
gene using siRNA has the great advantage that the eﬀect is
transient and does not jeopardize the genome organization.
Therefore, the use of siRNA will be an ideal diﬀerentiation
method for regenerative medicine and could be applied to
the adult stem cells to induce the desired cell types.
In this paper, we attempted to develop a novel method to
diﬀerentiate ES cells into an osteoblastic lineage by transiently
suppressing a key transcription factor PPARc using synthetic
siRNA. We show that siRNA against PPARc suppressed adi-
pocyte diﬀerentiation and successfully induced osteoblastic dif-
ferentiation in ES cells without using factors such as ascorbic
acid, b-glycerophosphate, Dex and BMP-2, which are known
to promote osteogenesis.2. Materials and methods
2.1. Mouse ES cell culture and diﬀerentiation
Mouse ES cells (SV6) were cultured with DMEM containing 15%
FCS, 0.1 mM 2-mercaptoethanol and 1000 U/ml leukemia inhibitory
factor (LIF, Invitrogen), as described previously [14]. To initiate diﬀer-
entiation, 1 · 103 cells were cultured with the ES medium without LIF
on the inner side of 100 mm culture dish lids and incubated at 37 C
with 5% CO2. By gravitational force, the cells condensed to form
embryoid bodies (EB). After two days of culture, 100 nM all-trans
RA was added to the medium and the cells were cultured for three
more days [15].
Then, EB were washed in PBS and trypsinized, and dissociated cells
(1 · 105 cells) were plated at 1 · 105 cells/ml onto a 35 mm culture dish
coated with 0.1% gelatin. Cells were cultivated using ES medium with-
out LIF.
For positive control of osteoblast and adipocyte diﬀerentiation, cells
were induced to diﬀerentiate using osteogenic supplements (OS: 50 lg/
ml ascorbic acid, 10 mM b-glycerophosphate, 100 nM Dex) and adipo-
genic supplements (AS: 0.5 mM 3-isobutyl-L-methylxanthine, 250 nM
Dex, and 100 nM insulin) as described previously [4,23].blished by Elsevier B.V. All rights reserved.
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We selected siRNAs corresponding to a conserved sequence (nucle-
otides 320–344; Accession No. NM_011146) to target transcripts of the
mouse PPARc gene (annealed oligos 5 0-AAUAUGACCUGAAG-
CUCCAAGAAUAAG-30 and 5 0-UAUUCUUGGAGCUUCAGGU-
CAUAUUAU-3 0, iGene, Japan). We also used a negative control
siRNA, whose sequence does not match any mouse genomic sequence
(annealed oligos 5 0-AUCCGCGCGAUAGUACGUAdTdT-3 0 and 5 0-
UACGUACUAUCGCGCGGAUdTdT-3 0, B-Bridge, Japan). Trans-
fection of siRNA was carried out on the day after the EB plating.
The conditions of the RNAi protocol were essentially as described pre-
viously [13,16]. Two micro liters of Lipofectamine 2000 (Invitrogen)
were mixed with 100 ll of Opti-MEM medium (Invitrogen) and incu-
bated for 5 min at room temperature. Two micro liters of pre-annealed
siRNAs (at a concentration of 20 lM) was diluted in 100 ll of Opti-
MEM medium, mixed with the diluted Lipofectamine and incubated
for another 20 min. The mixture was added to the cells (1 ml of ES
medium without LIF in 3.5 cm dish), giving a ﬁnal concentration of
33 nM RNA in the dish.A
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Fig. 1. Expression of marker genes characteristic of adipocytes.
Expression of PPARc (A) and aP2 (B) mRNAs was analyzed by
quantitative RT-PCR at 0 days (black bar; undiﬀerentiated mouse ES
cells), 5 days (black bar; RA-treated EB), 10 days, 15 days and 20 days
of diﬀerentiation. Cells transfected with control siRNA, PPARc-
siRNA, or treated with adipogenic supplements (AS) are indicated by
open, shaded, and hatched bars, respectively. Data are expressed as
means ± S.D. (n = 3); # and * indicate signiﬁcant diﬀerences compared
to cells transfected with control siRNA or treated with adipogenic
supplements, respectively; P < 0.05 with Student’s t test.2.3. RNA extraction and quantitative reverse transcription-polymerase
chain reaction
Total RNA was isolated from the cell culture using an RNeasy Mini
Kit (Qiagen) according to the manufacturer’s instructions. After DNase
treatment of the samples, reverse transcription was carried out using a
SuperScript III First-Strand Synthesis System (Invitrogen). Polymerase
chain reaction (PCR) reactions (50 ll) were carried out using Blend Taq
DNA Polymerase (TOYOBO, Japan) according to the manufacturer’s
instructions. The PCR conditions used were: 2 min at 94 C, followed
by 35 cycles of 15 s denaturation at 94 C, 30 s annealing at 55 C
and 30 s extension at 72 C. Ampliﬁed products were used to derive
standard curves for quantitative reverse transcription (RT)-PCR.
PCR reaction mix for quantitative RT-PCR was prepared using Light-
CyclerFastStart DNA Master SYBR Green I Kit (Roche). Mg2+ con-
centrations used for the PCR reaction were 3 mM. PCR conditions
for quantitative RT-PCR were as follows; activation of enzyme at
95 C for 10 min, 45 cycles of denaturation at 95 C for 15 s, annealing
at 60 C for 5 s and extension at 72 C for 20 s. For PPARc quantiﬁca-
tion, SYBR Premix Ex Taq Kit (Takara, Japan) was also used. The
condition of quantitative RT-PCR were as follows; activation of
enzyme at 95 C for 10 s, 45 cycles of denaturation at 95 C for 5 s,
annealing at 60 C for 20 s and extension at 72 C for 10 s. Quantitative
RT-PCR was carried out using the LightCycler Instrument (Roche)
and data were analyzed using LightCycler Software Ver.3. Fluores-
cence of each sample was determined after every cycle. All the melting
curves of PCR products gave a single peak with the same melting tem-
perature as the relevant control. Agarose gel electrophoresis of repre-
sentative reactions was carried out to conﬁrm ampliﬁcation of unique
fragments of predicted lengths. The expressions of marker genes were
normalized to the expression of b-actin.
Primer were designed based on the mouse sequence and BLAST-ed
for their speciﬁcity at the National Center for Biotechnology Informa-
tion (NCBI). Primer sequences (sense, antisense) were as follows.
PPARc (5 0-AAGAGCTGACCCAATGGTTG-3 0, 5 0-TCCATAGTG-
GAAGCCTGATGC-3 0), adipocyte-speciﬁc fatty acid binding protein
(aP2) (5 0-ATGTGTGATGCCTTTGTGGGA-3 0, 5 0-TGCCCTTTCA-
TAAACTCTTGT-3 0), collagen type 1 (5 0-CTGCCTGCTTCGTGT-
AAA-3 0, 5 0-ACGTTCAGTTGGTCAAAGGTA-30), osteopontin
(50-TCTCCTTGCGCCACAGAATG-30, 50-TCCTTAGACTCACCGC-
TCTT-3 0), Cbfa1 (5 0-CCGCACGACAACCGCACCAT-3 0, 5 0-CGC-
TCCGGCCCACAAATCTC-3 0), osteocalcin (5 0-TCTCTCTGCTCA-
CTCTGCTGG-30, 5 0-ACCGTAGATGCGTTTGTAGGC-30). b-Actin
(5 0-GGCCCAGAGCAAGAGAGGTATCC-3 0, 5 0-ACGCACGATT-
TCCCTCTCAGC-3 0).
2.4. Cell staining
2.4.1. Oil-red O staining and lipid accumulation assay. Lipid accu-
mulation was detected with Oil-red O at 20 days of diﬀerentiation,
as described previously [17]. For the analysis of lipid accumulation,
stained lipid was extracted with 100% isopropanol for 5 min and the
optical density of the solution was measured at 540 nm.
2.4.2. Alizarin Red S staining and calcium assay. Calciﬁcation was
identiﬁed with Alizarin Red S staining at 20 days of diﬀerentiation
[18]. Furthermore, the deposited calcium was extracted with 0.5 Macetic acid over night and the calcium content of the individual dish
was determined with the use of the calcium C-test Wako Kit (Wako,
Japan), which is based on the o-cresolphthalein complexon color devel-
opment method [19].
2.5. Statistical analysis
Means ± standard deviation (S.D.) were calculated and statistically
signiﬁcant diﬀerences between two groups were determined by Stu-
dent’s t test at P < 0.05.3. Results and discussion
The expression of PPARc was induced during the diﬀerenti-
ation process in hanging drop culture with RA (Fig. 1A, 5
days). After the adhesion of dissociated EBs, siRNA against
PPARc was transfected to suppress PPARc expression.
At 10 and 15 days of diﬀerentiation in adhesion culture, the
expression of PPARc, which is a marker gene in adipogenesis
[20], was signiﬁcantly suppressed in PPARc-siRNA-transfec-
ted cells, whereas upregulation was observed in cells transfec-
ted with control siRNA and cultured with AS (positive
control) (Fig. 1A). At 20 days of diﬀerentiation, the expression
in PPARc-siRNA-transfected cells was upregulated but still
low compared to that of controls (Fig. 1A). Interestingly, the
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(aP2) also remained low in PPARc-siRNA-transfected cells for
15 days (Fig. 1B). These results indicated that the expression of
not only PPARc, but also of aP2, was successfully downregu-
lated for 15 days by PPARc-siRNA transfection.
Then, we visualized the lipid accumulation using Oil-red O
staining. Control siRNA-transfected cells displayed signiﬁcant
lipid accumulation at 20 days of diﬀerentiation (Fig. 2A). In
PPARc-siRNA-transfected cells, the amount of stained lipid
was less than that of control siRNA-transfected cells
(Fig. 2B). We extracted stained lipid and measured its absor-
bance to compare lipid accumulation between control and
PPARc-siRNA-transfected cells. Although mouse ES cell
eventually become adipocytic even in basic medium under
these experimental conditions, a signiﬁcant reduction of absor-
bance was observed in PPARc-siRNA-transfected cells
(Fig. 2C). Recently, it has been reported that lentiviral and
adenoviral vector-mediated RNAi for PPARc inhibited prea-
dipocyte to adipocyte diﬀerentiation in 3T3-L1 cells [21,22].
Our results demonstrated that the transient suppression of
PPARc using synthetic siRNA inhibited adipocyte diﬀerentia-
tion and lipid accumulation per cell in mouse ES cells, suggest-
ing the importance of PPARc for adipocyte diﬀerentiation.
Next, we investigated osteoblast diﬀerentiation under the
same experimental conditions, except that the positive control
cells were cultured with OS. We measured expression of mar-
ker genes characteristic of osteoblast diﬀerentiation, such as
collagen type 1 (COL1), osteopontin (OP), Cbfa1 and osteo-
calcin (OC). Interestingly, the pattern of COL1 expression in
siRNA-transfected cells was diﬀerent from that of cells cul-
tured with OS (Fig. 3A). COL1 expression was immediately
upregulated in OS treated cells. On the other hand, it remainedC
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Fig. 2. Eﬀect of PPARc suppression in adipogenesis. Lipid accumulation wa
transfected with control siRNA or with (B) PPARc-siRNA. Scale bar indicat
the absorbance at 540 nm was measured (C). Bars as in Fig. 1. Data are ex
diﬀerences compared to cells transfected with control siRNA or treated withlow level for 15 days in siRNA-transfected cells. At 20 days, its
expression was upregulated in PPARc-siRNA transfected cells
and reached levels similar to those in the OS treated cells.
These results suggest that COL1 expression is diﬀerentially af-
fected by OS treatment vs. PPARc suppression using siRNA.
The expression of osteopontin was upregulated by RA treat-
ment, and then was gradually downregulated during the diﬀer-
entiation period. No substantial diﬀerence was observed
among the culture conditions used (Fig. 3B). On the other
hand, expression of Cbfa1 was gradually upregulated by
PPARc-siRNA transfection and a signiﬁcant diﬀerence from
control was observed at 15 days (Fig. 3C). In the case of
OC, a marker of mature osteoblasts, expression levels did
not diﬀer so much in any treatment until 15 days. However,
upregulation was detected in PPARc-siRNA-transfected cells
at 20 days of diﬀerentiation and the expression level was sim-
ilar to that in the positive control (Fig. 3D). Furthermore, we
examined calcium deposition with Alizalin Red S staining and
found obvious staining pattern only in PPARc-siRNA-trans-
fected cells (Fig. 4). We also measured the amount of accumu-
lated calcium using a colorimetric method [19]. We found that
approximately 4 times as much as calcium was accumulated in
PPARc-siRNA-transfected cells compared to control transfec-
ted cells, and the amount of accumulated calcium was equiva-
lent to that of OS treated cells at 20 days of diﬀerentiation
(Fig. 4C). These results demonstrated that the transient sup-
pression of PPARc promoted osteogenesis. It is notable that
we were able to diﬀerentiate ES cells into an osteoblastic line-
age without adding any osteogenic factors such as ascorbic
acid, b-glycerophosphate, Dex or BMPs. This is the ﬁrst report
to our knowledge that osteoblasts were produced from normal
ES cells (not PPARc deﬁcient cells) without using such factors.ntiation
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Fig. 3. Expression of marker genes characteristic of osteoblasts. Expressions of collagen type 1 (COL1)(A), osteopontin (OP)(B), Cbfa1 (Cbfa1)(C)
and osteocalcin (OC)(D) mRNAs were analyzed with quantitative RT-PCR at 0 day (black bar; undiﬀerentiated mouse ES cells), 5 days (black bar;
RA-treated EB), 10 days, 15 days and 20 days of diﬀerentiation. Cells transfected with control siRNA, PPARc-siRNA, or treated with osteogenic
supplements (OS) are indicated by open, shaded, and hatched bars, respectively. Data are expressed as means ± S.D. (n = 3); # and * indicate
signiﬁcant diﬀerences compared to cells transfected with control siRNA or treated with osteogenic supplements (P < 0.05, Student’s t test).
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Fig. 4. Eﬀect of PPARc suppression on osteogenesis. Calcium deposition was detected by Alizarin Red S staining at 20 days of diﬀerentiation in cells
transfected with control siRNA (A) or PPARc-siRNA (B). Scale bar indicates 100 lm. Calcium was extracted and quantiﬁed by the o-cresolphthalein
complexon color development method (C). Data are expressed as means ± S.D. (n = 4) per well; # and * indicate signiﬁcant diﬀerences compared to
cells transfected with control siRNA or treated with osteogenic supplements, respectively (P < 0.05, Student’s t test).
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ited adipocyte diﬀerentiation, and also induced osteoblast dif-
ferentiation in ES cells. Our data showed good agreement with
the previous observation using PPARc deﬁcient ES cells [11].
This could be due to the interaction of PPARc with TGF-b/
Smad3 signaling or due to sharing the same progenitors
[7,8]. However, the signaling of PPARc suppression to inhibit
adipogenesis and to induce osteogenesis needs to be elucidated
further.
Our data suggested that ES cell diﬀerentiation could be
modiﬁed by transient suppression of PPARc using chemically
synthesized siRNA. As synthetic siRNAs have advantages that
they are easy to transfect and do not modify genome organiza-
tion, we believe that this would be an ideal method for cell dif-
ferentiation for ES, adult stem and progenitor cells.
It is known that osteoblasts and adipocytes develop from
common progenitors by the activation of transcription factors
Cbfa1 and PPARc, respectively [11], and age-related osteopo-
rosis is accompanied by an increase in marrow adipose tissue
[7,8]. Previous studies have demonstrated that PPARc acts
to promote adipocyte vs. osteoblast diﬀerentiation [11]. Our re-
sults also support the notion that PPARc plays an important
role in controlling not only adipocyte, but also osteoblast dif-
ferentiation. In addition, these results suggest the possibility
that adipocyte and osteoblast diﬀerentiation could be con-
trolled by the transient suppression of PPARc using siRNA.
In summary, we showed that the transient suppression of
PPARc inhibited adipocyte diﬀerentiation and enhanced
osteoblast diﬀerentiation in ES cells without the use of osteo-
genic factors. Therefore, cell diﬀerentiation using the transient
suppression of speciﬁc genes with siRNA may provide a novel
approach in stem cell biology, regenerative medicine and gene
therapy.
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